Head-to-head · WeighScore
Luma Health Co vs Strut Health
The verdict
Strut Health takes it — 82/100 to 75/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Luma Health Co | Strut Health |
|---|---|---|
| WeighScore | 75/100 | 82/100 |
| Grade | C | B− |
| Scorecard rank | #59 | #21 |
| Semaglutide | $120/mo (plus a separate fee, compounded) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | $180/mo (compounded) | From $199/mo either route |
| Coverage | 30 states | 49 states (not Arkansas) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #59 · C
Strengths
- Transparent, competitive pricing published up front — compounded semaglutide from $120/mo, tirzepatide from $180/mo, retatrutide from $170/mo
- No subscription, monthly fee or membership — a direct-to-patient model where you pay per medication, and follow-up visits are free
- Free initial consults for first responders, law enforcement, military, nurses and teachers ($0), and $25 for other healthcare workers
- Founded and led by a named family nurse practitioner (Tiffani McKnight, FNP-C) licensed across 30 states/DC, with HIPAA-compliant virtual visits
- HSA/FSA funds and financing accepted, with itemized invoices for HSA/FSA submission
Where it loses points
- Offers compounded retatrutide (labeled "RTT/GLP-3"), an investigational triple agonist not FDA-approved — a higher-risk, less-studied option
- Compounded medications only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
- No LegitScript certification shown and no compounding-pharmacy partner named, so the dispensing pharmacy can't be independently verified
- Small, newly established founder-led practice with a thin website and limited public track record or third-party reviews
- Medication prices are "starting at" and billed on top of a one-time consult fee, so the true first-month cost runs higher than the headline
Graded #21 · B−
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
Where it loses points
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring programme
- Compounded only, with no brand-name lane
- Not available in Arkansas
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.